Onward Medical has unveiled a non-invasive wireless stimulator for bladder control, spasticity relief, and blood pressure management for people with spinal cord injuries. (SCI).
The U.S. Food and Drug Administration (FDA) has granted this novel innovation as a breakthrough device.
An external, non-invasive device called ARC-EX functions as a wireless programmer and stimulator.
Up-LIFT, the company's first pivotal trial, released encouraging top-line results in 2022. In order to increase upper extremity strength and function, the research examined ARC-EX therapy.
ONWARD is presently preparing for regulatory submissions in the U.S. and Europe to receive approval for commercialization by the end of 2023.
